Catalog Home Page

Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus

Hammond, T., Lee, S., Watson, M.W., Flexman, J.P., Cheng, W., Fernandez, S. and Price, P. (2010) Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus. Cellular Immunology, 264 (2). pp. 150-155.

Link to Published Version: http://dx.doi.org/10.1016/j.cellimm.2010.06.001
*Subscription may be required

Abstract

Toll-like receptor (TLR) expression on T-cells and the signalling pathways that lead to the production of cytokines may limit antigen-specific T-cell responses. Here, expression of TLR and retinoic acid inducible gene I (RIG-I) on T-cells were evaluated in patients chronically infected with hepatitis C virus (HCV), before and during pegylated interferon-α and ribavirin therapy. Expression of TLR2,3,4,7,9 and retinoic acid inducible gene (RIG)-I on different CD4+ and CD8+ T-cell sub-populations (naïve: CD45RA+CD57−; central memory: TCM CD45RA−CD57−; effector memory: TEM CD45RA−CD57+ and terminally differentiated effector memory: TEMRA CD45RA+CD57+) were measured by flow cytometry. TLR7, TLR9 and RIG-I expression on CD4+ T-cells and RIG-I expression on CD8+ T-cells was higher in patients than healthy controls. Therapy increased expression of TLR2, TLR4 and TLR9 and this was observed for all T-cell sub-populations. Evaluation of TLR expression at baseline did not identify patients able to achieve sustained virological response following therapy.

Publication Type: Journal Article
Publisher: Academic Press Inc.
Copyright: © 2010 Published by Elsevier Inc.
URI: http://researchrepository.murdoch.edu.au/id/eprint/31906
Item Control Page Item Control Page